Case report highlights rare dermatological reactions in a pediatric patient using dupilumab, indicating potential risks.
Dupilumab-associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab-associated erythema multiforme-like eruption in a 5-year-old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and lower limbs, with a biopsy suggestive of a lichenoid interface reaction. Dupilumab was discontinued, and the side effect was managed with topical corticosteroids, leading to resolution of the lesions with mild residual post-inflammatory skin hyperpigmentation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: